RGD-Functionalized Ginsenoside Rg3 Liposomes for Alleviating Oxidative Stress and Choroidal Neovascularization in Age-Related Macular Degeneration

RGD-Functionalized Ginsenoside Rg3 Liposomes for Alleviating Oxidative Stress and Choroidal Neovascularization in Age-Related Macular Degeneration

Jie Zhou,1,&ast; Dengminghong Zhao,1,&ast; Shaotian Niu,2 Weiwei Meng,1 Zhoujiang Chen,1 Hanmei Li,3 Ya Liu,2,4 Liang Zou,3 Wei Li2,5 1School of Pharmacy, Chengdu University, Chengdu, 610106, People’s Republic of China; 2State Key Laboratory of Southwestern Chinese Medicine Resources...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhou J, Zhao D, Niu S, Meng W, Chen Z, Li H, Liu Y, Zou L, Li W
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-06-01
Series:	International Journal of Nanomedicine
Subjects:	Multitargeted therapeutic Ginsenoside Rg3 Choroidal neovascularization CNV Age-related macular degeneration AMD
Online Access:	https://www.dovepress.com/rgd-functionalized-ginsenoside-rg3-liposomes-for-alleviating-oxidative-peer-reviewed-fulltext-article-IJN
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Rac1 overexpression promotes Treg-derived cytokines to mediate choroidal neovascularization in wet age-related macular degeneration
by: Juanjuan Li, et al.
Published: (2025-03-01)

Clinical features of focal choroidal excavation subtypes and their association with choroidal neovascularization
by: Yuhong Gan, et al.
Published: (2025-06-01)

Early detection of choroidal neovascularization in age related macular degeneration
by: Tural Galbinur
Published: (2014-07-01)

Choroidal neovascularization activity and structure by optical coherence tomography angiography in age related macular degeneration
by: M. A. Kovalevskaya, et al.
Published: (2021-12-01)

Effect of vascular endothelial growth factor inhibitors on choroid in patients with macular choroid neovascular membrane and degenerative myopia . Preliminary report
by: V. A. Solomin, et al.
Published: (2014-07-01)

Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGF
by: H. Mhmud, et al.
Published: (2025-06-01)

Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases
by: Mingyu Wu, et al.
Published: (2025-02-01)

Metformin inhibits pathological retinal neovascularization but promotes retinal fibrosis in experimental neovascular age-related macular degeneration
by: Xin Wang, et al.
Published: (2025-03-01)

Unraveling Ginsenoside Rg1’s osteoprotective pathways in zebrafish models of glucocorticoid induced osteoporosis via transcriptomics
by: Xinyu Fan, et al.
Published: (2025-08-01)

The Vascular Architecture of Macular Neovascularization in Age-Related Macular Degeneration as a Predictor of Therapy Requirements: A 3-Year Longitudinal Analysis
by: Michael Grün, et al.
Published: (2025-04-01)

Choroidal Osteoma with Choroidal Neovascularization and Focal Choroidal Excavation
by: Rajwinder Kaur, et al.
Published: (2021-10-01)

Ginsenoside Rg1 inhibits angiogenesis in diabetic retinopathy through the miR‐100‐3p/FBXW7/c‐MYC molecular axis
by: Liping Xue, et al.
Published: (2025-05-01)

Outcomes of Anti-VEGF Therapy in Eyes with Diabetic Macular Edema, Vein Occlusion-Related Macular Edema, and Neovascular Age-Related Macular Degeneration: A Systematic Review
by: Aldokhail LS, et al.
Published: (2024-12-01)

Ginsenoside Rg3 Adjunctively Increases the Efficacy of Gefitinib Against NSCLC by Regulating EGFR Copy Number
by: Xinyi Lv, et al.
Published: (2025-07-01)

Pharmacological mechanisms and drug delivery systems of ginsenoside Rg3: A comprehensive review
by: Zhong-Wei Yao, et al.
Published: (2025-06-01)

Intravitreal bevacizumab for neovascular age-related macular degeneration
by: Junn R. Pajarillo, MD, et al.
Published: (2009-12-01)

Comparison of optical coherence tomography vs. fluorescein angiography-based macular neovascularization classifications in age-related macular degeneration
by: Gábor G. Deák, et al.
Published: (2025-02-01)

Non-Invasive Diagnosis of Polypoidal Choroidal Vasculopathy as a Variant of the Course of Age-Related Macular Degeneration
by: I. E. Panova, et al.
Published: (2018-07-01)

Efficacy and mechanism of action of ginsenoside Rg3 on radiation proctitis in rats
by: Xuxia Li, et al.
Published: (2024-09-01)

Reduced choroidal vascular index and choroid structural changes extended beyond subfoveal area in chronic central serous chorioretinopathy eyes with macular neovascularization
by: Xiang-Gui Zhang, et al.
Published: (2025-05-01)

Double focal choroidal excavation with choroidal neovascularization
by: Sashwanthi Mohan, et al.
Published: (2025-01-01)

Subretinal Drug Delivery in Wet Age Related Macular Degeneration with Sub-macular Hemorrhage
by: Atul Kumar, et al.
Published: (2014-10-01)

Targeting and reprogramming microglial phagocytosis of neutrophils by ginsenoside Rg1 nanovesicles promotes stroke recovery
by: Kaichao Hu, et al.
Published: (2025-05-01)

The role of myeloid cell heterogeneity during spontaneous choroidal neovascularization in Vldlr knockout mice
by: Amrita Rajesh, et al.
Published: (2025-03-01)

The role of peripheral blood microRNAs in the pathogenesis and treatment response of age-related macular degeneration
by: Meng Kong, et al.
Published: (2025-12-01)

One-Year Outcomes in Subjects Developing Macular Neovascularization While Undergoing Avacincaptad Pegol Therapy for Geographic Atrophy
by: Rush RB, et al.
Published: (2025-01-01)

A Novel Ginsenoside-Transforming α-L-Rhamnosidase from <i>Bifidobacterium</i>: Screening, Characterization and Application
by: Chang-Hao Cui, et al.
Published: (2024-12-01)

12-month outcomes of ziv-aflibercept for neovascular age-related macular degeneration in eyes previously treated with aflibercept
by: Wajiha J Kheir, et al.
Published: (2025-01-01)

Ginsenoside Rg1 controls CKLF1-mediated apoptosis to reduce hypoxic/reoxygenation injury in HT22 cells
by: Jinping Liang, et al.
Published: (2025-04-01)

Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India – Multicentric, real-world study
by: Deependra Vikram Singh, et al.
Published: (2024-12-01)

Efficacy and Safety of Aflibercept Biosimilars Relative to Reference Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
by: Aljuhani HS, et al.
Published: (2025-06-01)

Vitrectomy for full-thickness macular hole developed during aflibercept treatment for wet age-related macular degeneration
by: Agnieszka Nowosielska
Published: (2024-12-01)

Clinical Evaluation of the Effectiveness of Neovascular Age-related Macular Degeneration Combined Treatment
by: L. A. Golota, et al.
Published: (2025-03-01)

Neurodegeneration and choroidal vascular features on OCT in the progression to advanced age-related macular degeneration
by: Inês Costa, et al.
Published: (2025-01-01)

Analysis of Clinical Study Results Obtained in Patients with Neovascular Age-Related Macular Degeneration in 2005–2020. Review
by: N. A. Gavrilova, et al.
Published: (2022-04-01)

Role of Optical Coherence Tomography-angiography in Diagnosis and Monitoring Activity of Macular Telangiectasia-associated Choroidal Neovascular Membrane
by: Mohd Azaz Quraishi, et al.
Published: (2024-07-01)

Ginsenoside Rg5 alleviates hypoxia-induced myocardial apoptosis by targeting STAT3 to promote Tyr705 phosphorylation
by: Fang-yang Li, et al.
Published: (2025-06-01)

Effect of Astragalus polysaccharide combined with Ginsenoside Rg3 on PD-1/PD-L1 in colon cancer
by: Wang Ya’nan, et al.
Published: (2024-02-01)

Photodynamic therapy for neovascular age-related macular degeneration
by: Richard P.L. Wormald, MA, MB, BCh, MSc, FRCS, FRCOphth, et al.
Published: (2005-06-01)

Kavain Alleviates Choroidal Neovascularization Via Decreasing the Activity of the HIF-1α/VEGF-A/VEGFR2 Signaling Pathway and Inhibiting Inflammation
by: Xi Chen, et al.
Published: (2024-07-01)